{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:41:12Z","timestamp":1773416472892,"version":"3.50.1"},"reference-count":21,"publisher":"Pacini Editore","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Otorhinolaryngol Ital"],"DOI":"10.14639\/0392-100x-a971","type":"journal-article","created":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:37:13Z","timestamp":1764682633000},"page":"431-436","source":"Crossref","is-referenced-by-count":2,"title":["Metastastic potential of middle ear neuroendocrine tumours"],"prefix":"10.14639","volume":"45","author":[{"given":"Michelle Sophia Dominique","family":"Engel","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik Frans","family":"Hensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Bloemena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik Johannes Leonardus","family":"van der Lans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles Ren\u00e9","family":"Leemans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Conrad Frits","family":"Smit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeroen","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"20340","published-online":{"date-parts":[[2025,12]]},"reference":[{"key":"10.14639\/0392-100X-A971_ref1","doi-asserted-by":"crossref","unstructured":"Engel MSD, van der Lans RJL, Jansen JC, et al. Management and outcome of middle ear adenomatous neuroendocrine tumours: a systematic review. Oral Oncolog 2021;121:105465. https:\/\/doi.org\/10-1016\/j.oraloncology.2021.105465","DOI":"10.1016\/j.oraloncology.2021.105465"},{"key":"10.14639\/0392-100X-A971_ref2","doi-asserted-by":"crossref","unstructured":"Mooney EE, Dodd LG, Oury TD, et al. Middle ear carcinoid: an indolent tumor with metastatic potential. Head Neck 1999;21:72-77. https:\/\/doi.org\/10.1002\/(SICI)1097-0347(199901)21:1<72::AID-HED10>3.0.CO;2-G","DOI":"10.1002\/(SICI)1097-0347(199901)21:1<72::AID-HED10>3.0.CO;2-G"},{"key":"10.14639\/0392-100X-A971_ref3","doi-asserted-by":"crossref","unstructured":"Ramsey MJ, Nadol JBJ, Pilch BZ, et al. Carcinoid tumor of the middle ear: clinical features, recurrences, and metastases. Laryngoscope 2005;115:1660. https:\/\/doi.org\/10.1097\/01.mlg.0000175069.13685.37","DOI":"10.1097\/01.mlg.0000175069.13685.37"},{"key":"10.14639\/0392-100X-A971_ref4","doi-asserted-by":"crossref","unstructured":"Pellini R, Ruggieri M, Pichi B, et al. A case of cervical metastases from temporal bone carcinoid. Head Neck 2005;27:644-647. https:\/\/doi.org\/10.1002\/hed.20197","DOI":"10.1002\/hed.20197"},{"key":"10.14639\/0392-100X-A971_ref5","doi-asserted-by":"crossref","unstructured":"Gaafar A, Ereno C, Ignacio Lopez J. Middle-ear carcinoid tumor with distant metastasis and fatal outcome. Hematol Oncol Stem Cell Ther 2008;1:53-56. https:\/\/doi.org\/10.1016\/S1658-3876(08)50061-6","DOI":"10.1016\/S1658-3876(08)50061-6"},{"key":"10.14639\/0392-100X-A971_ref6","unstructured":"Tabuchi K, Aoyagi Y, Uemaetomari I, et al. Carcinoid tumours of the middle ear. J Otolaryngol Neck Surg 2009;38:E91-94."},{"key":"10.14639\/0392-100X-A971_ref7","doi-asserted-by":"crossref","unstructured":"Salzman R, Starek I, Ticha V, et al. Metastasizing middle ear carcinoid: an unusual case report, with focus on ultrastructural and immunohistochemical findings. Otol Neurotol 2012;33:1418-1421. https:\/\/doi.org\/10.1097\/MAO.0b013e3182693888","DOI":"10.1097\/MAO.0b013e3182693888"},{"key":"10.14639\/0392-100X-A971_ref8","doi-asserted-by":"crossref","unstructured":"Fundakowski CE, Chapman JR, Thomas G. Middle ear carcinoid with distant osseous metastasis. Laryngoscope 2013;123:779-782. https:\/\/doi.org\/10.1002\/lary.23434","DOI":"10.1002\/lary.23434"},{"key":"10.14639\/0392-100X-A971_ref9","doi-asserted-by":"crossref","unstructured":"Bell D, El-Naggar AK, Widley PW. Middle ear adenomatous neuroendocrine tumors: a 25-year experience at MD Anderson Cancer Center. Virchows Arch 2017;471:667-672. https:\/\/doi.org\/10.1007\/s00428-017-2155-6","DOI":"10.1007\/s00428-017-2155-6"},{"key":"10.14639\/0392-100X-A971_ref10","doi-asserted-by":"crossref","unstructured":"Van der Lans RJL, Engel MSD, Rijken JA, et al. Neuroendocrine neoplasms of the middle ear: unpredictable tumor behaviour and tendency of recurrence. A single centre experience with nine patients. Head Neck 2021;43:1-6. https:\/\/doi.org\/10.1002\/hed.26658","DOI":"10.1002\/hed.26658"},{"key":"10.14639\/0392-100X-A971_ref11","doi-asserted-by":"crossref","unstructured":"Alciato L, Lahlou G, Tank\u00e9r\u00e9 F, et al. Middle ear adenomatous neuroendocrine tumours: single institution experience with five cases. Clin Otolaryngol 2021;46:1136-1141. https:\/\/doi.org\/10.1111\/coa.13791","DOI":"10.1111\/coa.13791"},{"key":"10.14639\/0392-100X-A971_ref12","doi-asserted-by":"crossref","unstructured":"Pollastri F, Pecci R, Pellegrini E, et al. Late onset middle ear neuroendocrine tumor presenting with distant metastasis. Otolaryngology Case Reports 2021;19:100289. https:\/\/doi.org\/10.1016\/j.xocr.2021.100289","DOI":"10.1016\/j.xocr.2021.100289"},{"key":"10.14639\/0392-100X-A971_ref13","doi-asserted-by":"crossref","unstructured":"Ratnayake GM, Luong TV, Toumpanakis C, et al. Middle ear neuroendocrine tumours: insight into their pathogenesis, diagnosis and management. J Neuroendocrinol 2021;33:E13031. https:\/\/doi.org\/10.1111\/jne.13031","DOI":"10.1111\/jne.13031"},{"key":"10.14639\/0392-100X-A971_ref14","unstructured":"Fisch U, Mattox D. Microsurgery of the skull base. First edition. Stuttgart: Georg Thieme Verlag; 1988."},{"key":"10.14639\/0392-100X-A971_ref15","doi-asserted-by":"crossref","unstructured":"Rindi G, Klimstra DS, Abedi-Ardekani B, et al. A common classification framework for neuroendocrine neoplasms: an International Agency for Research on Cancer (IARC) and World Health Organization (WHO) expert consensus proposal. Mod Pathol 2018;31:1770-1786. https:\/\/doi.org\/10.1038\/s41379-018-0110-y","DOI":"10.1038\/s41379-018-0110-y"},{"key":"10.14639\/0392-100X-A971_ref16","doi-asserted-by":"crossref","unstructured":"Miller HC, Drymousis P, Flora R, et al. Role of Ki-67 proliferation index in the assessment of patients with neuroendocrine neoplasias regarding the stage of disease. World J Surg 2014;38:1353-1361. https:\/\/doi.org\/10.1007\/s00268-014-2451-0","DOI":"10.1007\/s00268-014-2451-0"},{"key":"10.14639\/0392-100X-A971_ref17","doi-asserted-by":"crossref","unstructured":"Singh S, Hallet J, Rowsell C, et al. Variability of Ki67 labeling index in multiple neuroendocrine tumors specimens over the course of the disease. Eur J Surg Oncol 2014;40:1517-1522. https:\/\/doi.org\/10.1016\/j.ejso.2014.06.016","DOI":"10.1016\/j.ejso.2014.06.016"},{"key":"10.14639\/0392-100X-A971_ref18","doi-asserted-by":"crossref","unstructured":"Asa SL, Arkun K, Tischler AS, et al. Middle ear \u201cadenoma\u201d: a neuroendocrine tumor with predominant L cell differentiation. Endocr Pathol 2021;32:433-441. https:\/\/doi.org\/10.1007\/s12022-021-09684-z","DOI":"10.1007\/s12022-021-09684-z"},{"key":"10.14639\/0392-100X-A971_ref19","doi-asserted-by":"crossref","unstructured":"Del Rivero J, Perez K, Kennedy EB, et al. Systemic therapy for tumor control in metastatic well-differentiated gastroenteropancreatic neuroendocrine tumors: ASCO guideline. JCO 2023;41:5049-5067. https:\/\/doi.org\/10.1200\/JCO.23.01529","DOI":"10.1200\/JCO.23.01529"},{"key":"10.14639\/0392-100X-A971_ref20","doi-asserted-by":"crossref","unstructured":"Pavel M, Baudin E, Couvelard A, et al. ENETS consensus guidelines for the management of patients with liver and other distant metastases from neuroendocrine neoplasms of foregut, midgut, hindgut, and unknown primary. Neuroendocrinology 2012;95:157-176. https:\/\/doi.org\/10.1159\/000335597","DOI":"10.1159\/000335597"},{"key":"10.14639\/0392-100X-A971_ref21","doi-asserted-by":"crossref","unstructured":"Lee J, Choi J, Choi C, et al. Role of radiotherapy for pancreatobiliary neuroendocrine tumors. Radiat Oncol J 2013;31:125-130. https:\/\/doi.org\/0.3857\/roj.2013.31.3.125","DOI":"10.3857\/roj.2013.31.3.125"}],"container-title":["Acta Otorhinolaryngologica Italica"],"original-title":[],"link":[{"URL":"https:\/\/www.actaitalica.it\/article\/view\/971","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T13:38:00Z","timestamp":1764682680000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.actaitalica.it\/article\/view\/971"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":21,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"URL":"https:\/\/doi.org\/10.14639\/0392-100x-a971","relation":{},"ISSN":["1827-675X"],"issn-type":[{"value":"1827-675X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12]]},"article-number":"8"}}